Biotricity
BTCY • NASDAQ
Biotricity is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Waqaas Al-Siddiq.
CEOWaqaas Al-Siddiq
Next Earnings
Upcoming earnings announcement for Biotricity
Date
Wednesday, February 11, 2026 (in 3 days)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q3 2026
EPS Estimate
-$0.08
Revenue Estimate
$4.1M
Earnings History
Past 12 earnings reports for Biotricity
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q2 2026 | -$0.03 | — | $3.9MEst: $3.9M | -0.4% |  10-Q |
| Aug 14, 2025 | Q1 2026 | -$0.03 | — | $3.9MEst: $3.8M | +1.9% | 10-Q |
| Jul 17, 2025 | Q4 2025 | -$0.08Est: -$0.10 | +20.0% | $3.7MEst: $3.6M | +2.8% | 10-K/A |
| Feb 19, 2025 | Q3 2025 | -$0.01 | — | $3.7M | — | 10-Q/A |
| Nov 15, 2024 | Q2 2025 | -$0.01 | — | $3.3M | — | 10-Q |
| Aug 19, 2024 | Q1 2025 | -$0.08 | — | $3.2M | — | 10-Q |
| Jun 27, 2024 | Q4 2024 | -$0.27Est: -$0.36 | +24.7% | $3.2MEst: $3.2M | -0.7% | 10-K/A |
| Feb 20, 2024 | Q3 2024 | -$0.12Est: -$0.44 | +71.8% | $3.0MEst: $3.0M | -0.9% | — |
| Nov 14, 2023 | Q2 2024 | -$0.21Est: -$0.34 | +38.8% | $2.9MEst: $3.3M | -12.4% | — |
| Aug 15, 2023 | Q1 2024 | -$0.04Est: -$0.41 | +90.2% | $3.0MEst: $3.1M | -2.5% | — |
| Jun 30, 2023 | Q4 2023 | -$0.48Est: -$0.54 | +11.1% | $2.7MEst: $2.6M | +5.4% | — |
| Feb 14, 2023 | Q3 2023 | -$0.47Est: -$0.54 | +12.2% | $2.5MEst: $2.4M | +2.5% | — |